Close Menu

MilliporeSigma

The licenses provide non-exclusive access to the IP for research applications.

NEW YORK (GenomeWeb) – Though reverse transcription of RNA to cDNA is an essential first step for a growing number of genomics applications, researchers have long known of problems associated with RT and its effects on study results.

NEW YORK (GenomeWeb) – Sigma-Aldrich said today that its third quarter revenues were up 4 percent year over year.

NEW YORK (GenomeWeb) – Shares of omics research tools and molecular diagnostic firms continued on a bumpy ride in September as the GenomeWeb Daily News Index slipped a little more than 1 percent compared to the end of August.

NEW YORK (GenomeWeb) – A shareholder has filed a lawsuit to stop Merck KGaA's proposed $17 billion buy of Sigma-Aldrich, Shareholders Foundation, a legal monitoring and settlement claim filing service, said today.

NEW YORK (GenomeWeb) – Merck KGaA today announced that it will acquire Sigma-Aldrich for $17 billion.

NEW YORK (GenomeWeb) – Sigma-Aldrich today announced a gene editing partnership to provide the University of Michigan Medical School's Vector Core with its CRISPR technology, experimental design consultation, and dedicated gene editing bioinformaticians.

NEW YORK (GenomeWeb) – NEW YORK (GenomeWeb) – Sigma-Aldrich today reported a 3 percent increase in sales in the second quarter as revenues rose to $701 million from $681 million in the year-ago period.

NEW YORK (GenomeWeb) – Dow AgroSciences said today that Sigma-Aldrich will manufacture and supply zinc finger nuclease reagents for use with Dow AgroSciences' Exzact Precision Technology, a genome modification platform for plants.

NEW YORK (GenomeWeb) – Sigma-Aldrich today reported a 2 percent increase in its first-quarter sales as the firm fell short of the consensus analyst estimate on the top line but exceeded it on the bottom line.

Pages

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.